Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial - Bennouna, J; Sastre, J; Arnold, D; Osterlund, P; Greil, R; Van Cutsem, E (Lancet Oncol, 2013)